Charts, page-22

There is way to much focus on revenues even though I believe they will be better than expectations what will rerate this stock will be the now looming news items such as

1. The launch of Sk-11 RNA power with wand
2. The wave 11 product
3. The expected roll out of Olay into the US
4. News updates on Body Guard, Coty, surface cleaning, oral care, razor etc etc etc

This has always been what rerate the stock and we are heading into the season that should see significant news items

All my opinion only

Cheers